JPS6237017B2 - - Google Patents
Info
- Publication number
- JPS6237017B2 JPS6237017B2 JP59031877A JP3187784A JPS6237017B2 JP S6237017 B2 JPS6237017 B2 JP S6237017B2 JP 59031877 A JP59031877 A JP 59031877A JP 3187784 A JP3187784 A JP 3187784A JP S6237017 B2 JPS6237017 B2 JP S6237017B2
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- present
- collagen
- administration
- atelocollagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59031877A JPS60174726A (ja) | 1984-02-21 | 1984-02-21 | 注射用医薬組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59031877A JPS60174726A (ja) | 1984-02-21 | 1984-02-21 | 注射用医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60174726A JPS60174726A (ja) | 1985-09-09 |
JPS6237017B2 true JPS6237017B2 (enrdf_load_stackoverflow) | 1987-08-10 |
Family
ID=12343261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59031877A Granted JPS60174726A (ja) | 1984-02-21 | 1984-02-21 | 注射用医薬組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60174726A (enrdf_load_stackoverflow) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2537935B2 (ja) * | 1987-12-29 | 1996-09-25 | 住友製薬株式会社 | 生理活性物質の農縮・脱塩方法 |
JPH04113394U (ja) * | 1991-03-22 | 1992-10-02 | 東海ゴム工業株式会社 | ホース脈動吸収装置 |
NZ511792A (en) | 1998-11-20 | 2003-08-29 | Skyepharma Canada Inc | Dispersible phospholipid stabilized microparticles |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6097918A (ja) * | 1983-11-01 | 1985-05-31 | Sumitomo Chem Co Ltd | インタ−フエロン持続性製剤 |
JPS60112713A (ja) * | 1983-11-21 | 1985-06-19 | Sumitomo Chem Co Ltd | 有用な徐放性注射剤 |
JPS60126217A (ja) * | 1983-12-14 | 1985-07-05 | Sumitomo Chem Co Ltd | 長期徐放性製剤 |
-
1984
- 1984-02-21 JP JP59031877A patent/JPS60174726A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60174726A (ja) | 1985-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3122128B2 (ja) | ペプチド製剤 | |
JP5819733B2 (ja) | 障害および疾患に対する全身治療のためのTGF−βスーパーファミリーメンバー含有タンパク質の末梢投与 | |
JPH02101022A (ja) | 糖尿病治療用医薬組成物 | |
Gómez-Pérez et al. | Insulin therapy: current alternatives | |
JPH0780761B2 (ja) | 痛みのある疾患又はアレルギー性疾患の治療用組成物及び治療法 | |
WO1985005036A1 (en) | Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch | |
US4654324A (en) | Human proinsulin pharmaceutical formulations | |
JP2002530353A5 (enrdf_load_stackoverflow) | ||
US5964224A (en) | Method for treating amyotrophic lateral sclerosis and a therapeutic agent therefor | |
US6623732B1 (en) | Pharmaceutical formulation for nasal administration | |
CN101317846B (zh) | 一种用于戒毒、镇痛的河豚毒素制剂 | |
JP3697460B2 (ja) | Hgf含有製剤 | |
JPH08143449A (ja) | 徐放性局所麻酔用注射剤 | |
JPS6237017B2 (enrdf_load_stackoverflow) | ||
US20050118241A1 (en) | Platform for transdermal formulations (ptf) | |
KR20190117318A (ko) | 우수한 안정성을 갖는 데옥시콜린산 함유 주사제 조성물 및 이의 제조방법 | |
JP5819734B2 (ja) | TGF−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法 | |
US5140008A (en) | Human growth hormone unit dose for the treatment of intoxicated individuals | |
AU2001286092A1 (en) | Reduction of the electrocardiographic OT interval | |
WO2002022211A2 (en) | Reduction of the electrocardiographic ot interval | |
SU1706624A1 (ru) | Способ лечени опиумно-морфинных наркоманий | |
JPS63303931A (ja) | 経鼻投与用成長ホルモン放出活性物質製剤 | |
JPH0383931A (ja) | 低刺激性grf経鼻投与製剤 | |
JP2002529515A5 (enrdf_load_stackoverflow) | ||
NO863082L (no) | Preparat for intramuskulaer injeksjon av legemidler, vitaminer eller vaksiner. |